Harnessing data sources and methodologies,
including machine learning and artificial intelligence, can enable
companies to meet patient needs in an age of targeted
medicines
LONDON, March 23,
2022 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT),
a global leader in providing trusted information and insights to
accelerate the pace of innovation, today announced the release of a
new report, Walking the talk on patient centricity: An
actionable and measurable model for life science companies,
which provides analysis of personalized patient engagement and
identifies the key pillars of patient centricity. The report
explores how companies can infuse an ethos of patient centricity
throughout their operations, measure effective patient centricity,
ensure return on investment in patient-centered efforts and
identify what a mature patient-centric organization looks like –
with actionable steps that companies can take to build and
strengthen their organizations.
A broad trend toward greater patient centeredness has been
underway in the healthcare industry for more than a decade, but the
COVID-19 pandemic has intensified the urgency of realizing this
cultural transformation. Successful life science companies are
already beginning to build toward a world of personalized
medicines. These companies are reorienting their organizations and
cultures around patient need, establishing the processes, tools and
expertise needed to gather and act upon patient insights and using
these insights to generate feedback loops that enhance outcomes and
empower patients in their care.
While this transition will be a gradual process, life science
organizations laying the foundations today stand to realize great
value for the patients they serve, as well as their investors. This
year's report finds four pillars of patient centricity which will
enable organizations to produce increasingly personalized and
targeted drugs and biologics to better defined patient groups.
- Data inputs: It is critical to obtain social sentiment
analysis, primary market research to capture patient voices, real
world data to identify patient cohorts, potentially inform
biomarker and indication targeting 'real world data and social
analytics.
- Patient involvement: Gaining insight into the patient
experience and seeing how patients prioritize their needs is
critical throughout the preclinical phase. As a drug, device or
diagnostic is going to market, patients need to be informed and
educated about it, and life sciences companies need to be attuned
to their feedback to maximize adoption and patient benefit.
- A customer experience (CX) approach: Patient
organizations can provide critical input at this phase. Are they
being kept apprised of shifts in strategy (e.g., pursuing one
indication over another) and the reasons behind them? How can
companies meet patients where they're at with information,
education and support? What barriers to access and utilization are
patients meeting, and how can they be surmounted? In a recent
survey, 35% of U.S. patients report having been non-compliant with
treatment after filling a prescription with 44% of non-compliant
patients saying their doctor talked to them about the importance of
taking their medication as prescribed.1
- A real-world mindset: How do patients view their
condition and treatments? What are their most pressing concerns and
unmet needs? What sorts of solutions would help them address these
pain points? As drugs, devices and diagnostics move out of a
clinical environment and into the real world, there are always
unanticipated hitches, from market access to package design. Are
companies attuned to the challenges confronting patients in
accessing and getting value from their products?
The full Patient Centricity Report can be accessed here.
Mike Ward, Global Head of Life
Sciences and Healthcare Thought Leadership,
Clarivate: "Alongside the growing trend for precision and
personalized medicines it is becoming increasingly apparent that
insights from patients can have a positive impact across the whole
of the discovery, development and delivery timeline of new
treatments. The challenge is how companies can best ensure that
those insights are efficiently incorporate into their discovery and
development processes."
Clarivate is committed to supporting customers across the entire
drug, device and medical technology lifecycles to advance, create
and protect innovation. By combining patient journey data,
therapeutic area expertise, artificial intelligence and analytics
in ways that unlock hidden insights, data-driven decisions and
accelerate innovation, Clarivate's end-to-end research intelligence
is designed to enable customers to make informed evidence-based
decisions and better understand the changing landscape.
Join the conversation, use hashtag #PatientCentricity and
mention Clarivate for Life Sciences & Healthcare on
Twitter and LinkedIn.
Methodology for the Report
Clarivate contributors analyzed multiple data sets and partnered
with internal and external subject matter experts, industry
executives and patient advocates to provide analysis of patient
centricity in the life science industries. Leveraging data and
insights from Clarivate patient surveys and studies of the life
sciences commercial landscape, the report provides a unified view
of the state of patient centricity and company efforts toward
greater patient-directedness.
To learn more about Clarivate data products,
visit www.clarivate.com.
About Clarivate
Clarivate™ is a global leader in providing solutions to
accelerate the pace of innovation. Our bold mission is to help
customers solve some of the world's most complex problems by
providing actionable information and insights that reduce the time
from new ideas to life-changing inventions in the areas of Academia
& Government, Life Sciences & Healthcare, Professional
Services and Consumer Goods, Manufacturing & Technology. We
help customers discover, protect and commercialize their inventions
using our trusted subscription and technology-based solutions
coupled with deep domain expertise. For more information, please
visit clarivate.com.
Media Contact
Catherine Daniel
Director, External Communications, Life Sciences &
Healthcare
media.enquiries@clarivate.com
1 Source: Cybercitizen Health U.S. 2021; Clarivate,
[online], Available at:
https://clarivate.com/products/research-reports/report/manpq1721-digital-cybercitizen-health-u-s-2021/?lid=d
View original content to download
multimedia:https://www.prnewswire.com/news-releases/clarivate-patient-centricity-report-underscores-need-for-evolution-from-selling-products-to-building-relationships-301508102.html
SOURCE Clarivate Plc